Hisamitsu enters the Parkinson's fray with transdermal candidate
This article was originally published in Scrip
Executive Summary
The transdermal delivery specialist Hisamitsu has begun the Phase II development in Japan of a patch product containing ropinirole for the treatment of Parkinson's disease.